Table 1.
The results of the examinations and treatment courses of the patient
| Date | Bone Marrow Cells | Peripheral cells | Treatment | ||||
|---|---|---|---|---|---|---|---|
| Myeloblast% | Dysplasia | LAP | WBC(X109/L) | Hb(g/L) | Plt(X109/L) | ||
| 21/03/14 | 1 | granulocytes | 387,100% | 85,N:90% | 74 | 62 | Hu |
| 27/03/14 | 2.6 | granulocytes | NA | 14, N:85% | 60 | 29 | Hu |
| 31/03/14 | 25, N:89% | 83 | 25 | Hu | |||
| 11/05/14 | 34,N:92% | 62 | 3 | Transfused | |||
| 14/05/14 | 1.6 | granulocytes | 387,100% | Transfused | |||
| 17/05/14 | 53,N:92% | 65 | 5 | Transfused | |||
| 19/05/14 | 66,N:90% | 60 | 21 | Transfused | |||
| 22/05/14 | 67,N:92% | 56 | 11 | Transfused | |||
| 25/05/14 | 64,N:94% | 67 | 5 | Bleeding Transfused, | |||
| 26/05/14 | 116,N:93% | 34 | 7 | Transfused | |||
| 27/05/14 | 90,N:85% | 33 | 29 | Died | |||
It displayed the examinations of bone marrow and peripheral cells at the process of the diagnosis and treatment courses of the patient